CASI Pharmaceuticals, Inc. (CASI)
NASDAQ: CASI · IEX Real-Time Price · USD
2.420
+0.120 (5.22%)
At close: Apr 26, 2024, 4:00 PM
2.348
-0.072 (-2.98%)
After-hours: Apr 26, 2024, 7:43 PM EDT
CASI Pharmaceuticals Revenue
In the year 2023, CASI Pharmaceuticals had annual revenue of $33.88M, a decrease of -21.41%. Revenue in the quarter ending December 31, 2023 was $6.87M, a -54.95% decrease year-over-year.
Revenue (ttm)
$33.88M
Revenue Growth
-21.41%
P/S Ratio
0.96
Revenue / Employee
$192,494
Employees
176
Market Cap
32.43M USD
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 33.88M | -9.23M | -21.41% |
Dec 31, 2022 | 43.11M | 12.94M | 42.89% |
Dec 31, 2021 | 30.17M | 15.03M | 99.25% |
Dec 31, 2020 | 15.14M | 11.01M | 266.52% |
Dec 31, 2019 | 4.13M | - | - |
Dec 31, 2018 | 0 | - | - |
Dec 31, 2017 | 0 | - | - |
Dec 31, 2016 | 0 | - | - |
Dec 31, 2015 | 47.71K | 23.99K | 101.09% |
Dec 31, 2014 | 23.73K | - | - |
Dec 31, 2013 | 0 | - | - |
Dec 31, 2012 | 669.31K | -1.27M | -65.52% |
Dec 31, 2011 | 1.94M | -1.75M | -47.45% |
Dec 31, 2010 | 3.69M | -1.59M | -30.11% |
Dec 31, 2009 | 5.28M | -2.19M | -29.33% |
Dec 31, 2008 | 7.48M | 81.57K | 1.10% |
Dec 31, 2007 | 7.40M | 501.29K | 7.27% |
Dec 31, 2006 | 6.89M | 976.30K | 16.50% |
Dec 31, 2005 | 5.92M | 5.40M | 1,051.38% |
Dec 31, 2004 | 514.00K | -1.06M | -67.38% |
Dec 31, 2003 | 1.58M | 399.06K | 33.92% |
Dec 31, 2002 | 1.18M | -685.45K | -36.81% |
Dec 31, 2001 | 1.86M | -1.81M | -49.29% |
Dec 31, 2000 | 3.67M | -1.35M | -26.82% |
Dec 31, 1999 | 5.02M | -143.93K | -2.79% |
Dec 31, 1998 | 5.16M | 404.00K | 8.49% |
Dec 31, 1997 | 4.76M | 132.49K | 2.86% |
Dec 31, 1996 | 4.63M | 3.91M | 550.34% |
Dec 31, 1995 | 711.17K | 620.98K | 688.57% |
Dec 31, 1994 | 90.19K | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Nutex Health | 247.65M |
Retractable Technologies | 43.60M |
Spectral AI | 18.06M |
ImmunoPrecise Antibodies | 17.67M |
Lucid Diagnostics | 2.43M |
CASI News
- 19 days ago - CASI PHARMACEUTICALS REPORTS DEVELOPMENT RELATING TO ITS DISPUTES WITH JUVENTAS - PRNewsWire
- 4 weeks ago - CASI PHARMACEUTICALS ANNOUNCES FOURTH QUARTER AND FULL-YEAR 2023 BUSINESS AND FINANCIAL RESULTS - PRNewsWire
- 7 weeks ago - CASI Pharmaceuticals Report Positive Interim Phase 1 Data For BI-1206 In The Treatment Of Relapsed/Refractory Indolent Non-Hodgkin's Lymphoma In China - PRNewsWire
- 2 months ago - CASI PHARMACEUTICALS ANNOUNCES FIRST DOSING OF FOLOTYN® IN CHINA - PRNewsWire
- 5 months ago - CASI PHARMACEUTICALS ANNOUNCES THIRD QUARTER 2023 BUSINESS AND FINANCIAL UPDATES - PRNewsWire
- 6 months ago - CASI PHARMACEUTICALS ANNOUNCES MARKET APPROVAL OF CNCT19 BY CHINA NMPA - PRNewsWire
- 9 months ago - CASI PHARMACEUTICALS ANNOUNCES SECOND QUARTER 2023 BUSINESS AND FINANCIAL UPDATES - PRNewsWire
- 9 months ago - Mundipharma International Corporation Limited, Mundipharma Medical Company, and Acrotech Biopharma Inc. Enter Agreement to Transfer License of FOLOTYN® (Pralatrexate) in China to CASI Pharmaceuticals - PRNewsWire